Alimera Sciences, Inc. (ALIM)
USD 5.54
(-0.18%)
USD 5.54
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 80.75 Million | 54.12 Million | 59.02 Million | 50.82 Million | 53.94 Million | 46.97 Million |
| Cost of Revenue | 19.58 Million | 7.97 Million | 7.03 Million | 6.94 Million | 6.62 Million | 4.67 Million |
| Gross Profit | 61.17 Million | 46.15 Million | 51.99 Million | 43.87 Million | 47.31 Million | 42.29 Million |
| Operating Expenses | 62.64 Million | 57.79 Million | 52.2 Million | 44.38 Million | 52.59 Million | 51.96 Million |
| Selling, General and Administrative Expenses | 46.01 Million | 38.85 Million | 35.84 Million | 32.03 Million | 38.95 Million | 38.04 Million |
| Research and Development Expenses | 16.62 Million | 16.22 Million | 13.77 Million | 9.66 Million | 10.99 Million | 11.27 Million |
| Other Expenses | - | 2.7 Million | 2.57 Million | 2.67 Million | 2.64 Million | 2.64 Million |
| Cost and Expenses | 82.22 Million | 65.76 Million | 59.23 Million | 51.32 Million | 59.21 Million | 56.64 Million |
| Operating Income | -1.47 Million | -11.64 Million | -201 Thousand | -501 Thousand | -5.27 Million | -9.67 Million |
| Interest Expense | 10.18 Million | 5.88 Million | 5.41 Million | 5.38 Million | 4.86 Million | 4.77 Million |
| Income Tax Expense | 85 Thousand | 28 Thousand | 438 Thousand | -68 Thousand | 216 Thousand | 106 Thousand |
| Earnings before Tax | -20.04 Million | -18.07 Million | -3.93 Million | -5.4 Million | -10.22 Million | -16.27 Million |
| Net Income | -20.13 Million | -18.1 Million | -4.37 Million | -5.33 Million | -10.44 Million | -16.38 Million |
| Earnings Per Share Basic | -0.79 | -2.59 | -0.66 | -1.04 | -2.19 | -3.51 |
| Earnings Per Share Diluted | -0.79 | -2.59 | -0.66 | -1.04 | -2.19 | -3.47 |
| Weighted Average Shares Outstanding | 25.56 Million | 6.99 Million | 6.59 Million | 5.11 Million | 4.77 Million | 4.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.56 Million | 6.99 Million | 6.59 Million | 5.11 Million | 4.77 Million | 4.71 Million |
| Gross Margin | 0.76 | 0.85 | 0.88 | 0.86 | 0.88 | 0.90 |
| EBIT Margin | 0.09 | -0.17 | 0.04 | 0.04 | -0.05 | -0.15 |
| Profit Margin | -0.25 | -0.33 | -0.07 | -0.11 | -0.19 | -0.35 |
| EBITDA | 7.27 Million | -8.93 Million | 2.37 Million | 2.17 Million | -2.63 Million | -7.02 Million |
| Earnings Before Tax Margin | -0.02 | -0.22 | -0.00 | -0.01 | -0.10 | -0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 27 Million | 23.01 Million | 80.75 Million | 26.3 Million | 23.36 Million | 17.53 Million |
| Cost of Revenue | 6.92 Million | 6.43 Million | 19.58 Million | 6.66 Million | 2.75 Million | 2.42 Million |
| Gross Profit | 20.07 Million | 16.57 Million | 61.17 Million | 19.64 Million | 20.6 Million | 15.11 Million |
| Operating Expenses | 20.13 Million | 18.69 Million | 62.64 Million | 18.45 Million | 15.99 Million | 16.32 Million |
| Selling, General and Administrative Expenses | 15.87 Million | 14.33 Million | - | 13.68 Million | 11.54 Million | 10.8 Million |
| Research and Development Expenses | 4.26 Million | 4.36 Million | - | 4.76 Million | 4.04 Million | 3.64 Million |
| Other Expenses | - | - | - | -1.08 Million | 402 Thousand | - |
| Cost and Expenses | 27.06 Million | 25.13 Million | 82.22 Million | 25.12 Million | 18.75 Million | 18.74 Million |
| Operating Income | -62 Thousand | -2.12 Million | -1.47 Million | 1.18 Million | 1.85 Million | -1.2 Million |
| Interest Expense | 3.15 Million | 3.73 Million | 10.18 Million | 4.75 Million | -2.07 Million | 1.69 Million |
| Income Tax Expense | -43 Thousand | -32 Thousand | 85 Thousand | 7000.00 | -53 Thousand | 25 Thousand |
| Earnings before Tax | -3.35 Million | -6.28 Million | -20.04 Million | -3.77 Million | -1.4 Million | -10 Million |
| Net Income | -3.31 Million | -6.25 Million | -20.13 Million | -3.78 Million | -1.35 Million | -10.02 Million |
| Earnings Per Share Basic | -0.06 | -0.11 | - | -0.07 | -0.04 | -1.24 |
| Earnings Per Share Diluted | -0.06 | -0.11 | - | -0.07 | -0.04 | -1.24 |
| Weighted Average Shares Outstanding | 54.38 Million | 54.35 Million | 25.56 Million | 54.42 Million | 32.1 Million | 8.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.38 Million | 54.35 Million | 25.56 Million | 54.42 Million | 32.1 Million | 8.09 Million |
| Gross Margin | 0.74 | 0.72 | 0.76 | 0.75 | 0.88 | 0.86 |
| EBIT Margin | 0.11 | 0.04 | - | 0.16 | -0.27 | 0.04 |
| Profit Margin | -0.12 | -0.27 | -0.25 | -0.14 | -0.06 | -0.57 |
| EBITDA | 3.03 Million | 959 Thousand | - | 4.22 Million | -6.23 Million | 658 Thousand |
| Earnings Before Tax Margin | -0.00 | -0.09 | -0.02 | 0.05 | 0.08 | -0.07 |
BFUTILITIE
9070
XMEX
001256
STHO
002982